New Analyses on Lecanemab Suggest Sustained Benefits Even After DiscontinuationBy MCA TeamMay 3, 20230 In Asia Pacific, the number of people suffering from dementia is set to triple from 23 million in 2015 to 71 million by 2050.
Use of Hybrid Closed-Loop System in Children with Type 1 DiabetesBy MCA TeamApril 27, 20230 Despite years of research, the aetiology of Type 1 Diabetes Mellitus (T1DM) remains elusive. Read this article to know more
Teplizumab: Monoclonal Antibody Treatment for T1DM that was recently approved by FDABy Tony ZhangApril 26, 20230 Teplizumab is a CD3-directed monoclonal antibody (mAb) that is a genetically modified derivative of the CD3-directed murine OKT3 mAb.
Daprodustat (Jesduvroq): First oral treatment for anaemia due to CKD in adult dialysis patientsBy ShanPingApril 25, 20230 Anaemia is a frequent complication of CKD associated with increased morbidity, higher healthcare costs and reduced quality of life.
The launch of Dexcom G6 real-time continuous glucose monitoring (rtCGM) in SingaporeBy Vanessa LooApril 20, 20230 The introduction of CGM devices has revolutionalised the management of both Type 1 and Type 2 diabetes with fewer fingerstick tests.
Goodbye to Migraines in Just 15 Minutes with Pfizer’s Zavegepant Nasal Spray – FDA Gives Green Light!By Tony ZhangApril 19, 20230 The mechanism of action of zavegepant is based on the positive relationship4 between serum concentration of CGRP and acute migraine attacks.
Semaglutide (Rybelsus®) receives FDA approval as first line treatment for Type 2 Diabetes MellitusBy ShanPingApril 7, 20230 Semaglutide, available in oral and subcutaneous dosage forms, is a selective glucagon-like peptide-1 receptor agonist with 3 main mechanisms of action.
Breast Cancer in Asian and Non-Hispanic White Women: Current State of Medical StudiesBy Tony ZhangMarch 24, 20230 In 2020, 2.3 million new breast cancer cases were diagnosed worldwide, overtaking lung cancer as the most common cancer.
Youth-onset Type 2 Diabetes: West vs AsiaBy Tony ZhangMarch 17, 20230 In recent years, studies have shown an increasing number of children, adolescents and young adults being diagnosed with type 2 diabetes
FDA Approves Xenoview for Use with MRI for the Evaluation of Lung VentilationBy KayeJanuary 27, 20230 In Dec 2022, Xenoview™, a hyperpolarized contrast agent prepared from a proprietary Xenon 129Xe Gas Blend, received FDA approval
